A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure FDA-cleared Instrument Exit Point (IEP), the first real-time AI application for robotic procedures from Medtronic, advances a precise, predictable, and personalized future for surgery GALWAY, Ireland, July 21, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, is presenting an early look at its next-generation compute platform for the operating room. Touch Surgery™ Aide — an AI-native surgical computing platform that powers the Touch Surgery™ ecosystem — enables real-time artificial intelligence during procedures.

PRNewsWire • Jul 21, 2026

Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors

Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.

Zacks Investment Research • Jul 21, 2026

Medtronic to announce financial results for its first quarter of fiscal year 2027

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, 2026. A news release containing summary financial information will be issued at 5:45 a.m.

PRNewsWire • Jul 20, 2026

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹ GALWAY, Ireland, July 16, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of SPR Therapeutics, Inc. (SPR), a privately held medical technology company and recognized leader in short-term, percutaneous peripheral nerve stimulation (PNS) therapies for chronic and acute pain management.

PRNewsWire • Jul 16, 2026

Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider

Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.

Zacks Investment Research • Jul 10, 2026

Medtronic: Undervalued, And The Tailwinds Are Just Getting Started

I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.

Seeking Alpha • Jul 10, 2026

Medtronic: Guidance Built To Be Beaten - Buy

Medtronic plc is rated buy with a $92 price target, reflecting conservative fiscal 2027 guidance and resilient growth platforms. Fiscal 2026 delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions outpacing market rates. Guidance for fiscal 2027 excludes potential catalysts—MiniMed separation, tariff refunds, and Blackstone payment relief—implying room for upside surprises.

Seeking Alpha • Jul 10, 2026

Medtronic: A Near Decade High Dividend For This Aristocrat

Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity. The company is experiencing strong revenue growth, driven by its leading positions in cardiovascular and neuroscience medical devices. While current free cash flow payout ratios are sustainable, investors should monitor future dividend growth rates closely.

Seeking Alpha • Jul 9, 2026

3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)

AbbVie is hitting its stride now that it has transitioned past Humira's patent expiration. Medtronic is a steady dividend payer with some intriguing upside in robotics-assisted surgery.

The Motley Fool • Jul 7, 2026

Why Is Medtronic (MDT) Up 1.5% Since Last Earnings Report?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Jul 3, 2026